no abstract

Bertrums, E. J. M., Zwaan, C. M., Hasegawa, D., De Haas, V., Reinhardt, D. N., Locatelli, F., De Moerloose, B., Dworzak, M., Buijs, A., Smisek, P., Kolenova, A., Pronk, C. J., Klusmann, J. -., Carbone, A., Ferster, A., Antoniou, E., Meshinchi, S., Raimondi, S. C., Niemeyer, C. M., Hasle, H., Van Den Heuvel-Eibrink, M. M., Goemans, B. F., Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS, <<HAEMATOLOGICA>>, 2022; 107 (3): 759-4764. [doi:10.3324/haematol.2021.279507] [https://hdl.handle.net/10807/229766]

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS

Locatelli, Franco
Writing – Review & Editing
;
2022

Abstract

no abstract
2022
Inglese
Bertrums, E. J. M., Zwaan, C. M., Hasegawa, D., De Haas, V., Reinhardt, D. N., Locatelli, F., De Moerloose, B., Dworzak, M., Buijs, A., Smisek, P., Kolenova, A., Pronk, C. J., Klusmann, J. -., Carbone, A., Ferster, A., Antoniou, E., Meshinchi, S., Raimondi, S. C., Niemeyer, C. M., Hasle, H., Van Den Heuvel-Eibrink, M. M., Goemans, B. F., Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS, <<HAEMATOLOGICA>>, 2022; 107 (3): 759-4764. [doi:10.3324/haematol.2021.279507] [https://hdl.handle.net/10807/229766]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/229766
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 2
social impact